BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16858161)

  • 1. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
    Alberts SR; Novotny PJ; Sloan JA; Danella J; Bostwick DG; Sebo TJ; Blute ML; Fitch TR; Levitt R; Lieberman R; Loprinzi CL
    Am J Ther; 2006; 13(4):291-7. PubMed ID: 16858161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
    Alberts SR; Blute ML
    Urology; 2001 Apr; 57(4 Suppl 1):188-90. PubMed ID: 11295624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Zhigang Z; Wenlu S
    Int J Cancer; 2008 Feb; 122(4):864-70. PubMed ID: 17957793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
    J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral orchidectomy and flutamide versus orchidectomy alone in newly diagnosed patients with metastatic carcinoma of the prostate--an Australian multicentre trial.
    Zalcberg JR; Raghaven D; Marshall V; Thompson PJ
    Br J Urol; 1996 Jun; 77(6):865-9. PubMed ID: 8705223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
    Moinpour CM; Savage MJ; Troxel A; Lovato LC; Eisenberger M; Veith RW; Higgins B; Skeel R; Yee M; Blumenstein BA; Crawford ED; Meyskens FL
    J Natl Cancer Inst; 1998 Oct; 90(20):1537-44. PubMed ID: 9790546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D; Auskalnis S; Skulcius G; Gudinaviciene I; Jievaltas M; Joniau S
    World J Urol; 2017 May; 35(5):721-728. PubMed ID: 27644229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
    Price D; Stein B; Sieber P; Tutrone R; Bailen J; Goluboff E; Burzon D; Bostwick D; Steiner M
    J Urol; 2006 Sep; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of irradiation and androgen ablation on prostatic intraepithelial neoplasia.
    Wheeler TM
    Eur Urol; 1996; 30(2):261-4. PubMed ID: 8875209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.
    Steiner MS; Pound CR
    Clin Prostate Cancer; 2003 Jun; 2(1):24-31. PubMed ID: 15046680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
    Lieberman R
    Urology; 2001 Aug; 58(2 Suppl 1):83-90. PubMed ID: 11502457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
    Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
    Nomura M; Sato H; Fujimoto N; Matsumoto T
    Int J Urol; 2004 Sep; 11(9):798-800. PubMed ID: 15379950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.